Irna Sufiawati
Overview
Explore the profile of Irna Sufiawati including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
132
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salsabila S, Khairinisa M, Wathoni N, Sufiawati I, Mohd Fuad W, Khairul Ikram N, et al.
Artif Cells Nanomed Biotechnol
. 2025 Feb;
53(1):1-15.
PMID: 39924869
Chitosan nanoparticles have been extensively utilised as polymeric drug carriers in nanoparticles formulations due to their potential to enhance drug delivery, efficacy, and safety. Numerous toxicity studies have been previously...
2.
Bakti F, Sufiawati I
Int Med Case Rep J
. 2025 Jan;
18():41-52.
PMID: 39811101
Introduction: The Behçet's Disease Current Activity Form (BDCAF) is crucial for monitoring the progression and treatment efficacy of Behçet's Disease (BD), an autoimmune disorder that can be triggered or exacerbated...
3.
Nuraeny N, Widiasta A, Novianti Y, Zakiawati D, Pratidina N, Sufiawati I
Diabetes Metab Syndr Obes
. 2025 Jan;
18():75-83.
PMID: 39802621
Background: Diabetes mellitus (DM) is a chronic disease that remains a global health problem with increasing prevalence, particularly in Indonesia. The presence of oral manifestations in patients with DM is...
4.
Santoso A, Amalia E, Indah Sari K, Takarini V, Sufiawati I
J Exp Pharmacol
. 2024 Oct;
16:377-395.
PMID: 39469135
Introduction: Oral mucosal wounds present significant clinical challenges due to their susceptibility to infection, inflammation, and delayed healing. The limitation of standard anti-inflammatory drugs (both steroidal and non-steroidal) highlights the...
5.
Wahyuni I, Diina T, Salsabila A, Khairinisa M, Sufiawati I, Levita J, et al.
Heliyon
. 2024 Sep;
10(16):e35827.
PMID: 39224366
The global incidence of recurrent aphthous stomatitis in 2018 reached 5-66 % of the population, while in Indonesia 8 %. Moreover, the prevalence of oral mucosal fibrosis and recurrent aphthous...
6.
Sufiawati I, Piliang A, Yusuf A, Dewi T, Agustina H, Azhar Y, et al.
Cancer Manag Res
. 2024 Aug;
16:1053-1061.
PMID: 39183757
Purpose: This study aimed to investigate the clinicopathological characteristics of oral squamous cell carcinoma (OSCC) patients and analyze the relationship between the degree of differentiation and factors including age, sex,...
7.
Permatasanti A, Sufiawati I
HIV AIDS (Auckl)
. 2024 Jul;
16:289-299.
PMID: 39081499
Introduction: Human immunodeficiency virus (HIV) impairs immune function leading to oral mucosal lesions. While highly active antiretroviral therapy (HAART) has reduced the incidence of HIV-associated oral lesions (HIV-OLs), these lesions...
8.
Hasanah N, Sufiawati I, Kusumadjati A, Sunardi M
J Lasers Med Sci
. 2024 Jul;
15:e11.
PMID: 39051003
Studies on head and neck cancer (HNC) patients undergoing radiotherapy have revealed increased numbers of spp., leading to oral candidiasis and oral mucositis. The effects of laser therapy on spp....
9.
Wahyuni I, Sufiawati I, Shafuria A, Nittayananta W, Levita J
Pharmaceutics
. 2024 Mar;
16(3).
PMID: 38543315
The rhizome of (Zingiberaceae) is extensively used in traditional medicine by utilizing its various biological activities. It has been proven that ethyl--methoxycinnamate (EPMC) and other polyphenolic compounds are present in...
10.
Hartanto F, Sufiawati I
Dent Med Probl
. 2024 Mar;
61(1):145-152.
PMID: 38441309
Systemic lupus erythematosus (SLE) is an autoimmune disease with various oral manifestations, including ulceration, white keratotic plaques, oral discoid lupus erythematosus, oral lichen planus (OLP)-like lesions, non-specific erythema, purpura, petechiae,...